SCHEMBL4229672

SCHEMBL4229672

NCCc1nc2ccsc2c(=O)n1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
RAB9A P51151 2/20 0.54
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
GAA P10253 1/20 0.54
TSHR P16473 1/20 0.48
PDE4B Q07343 2/20 0.48
PDE4A P27815 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
PDE3B Q13370 1/20 0.48
PDE3A Q14432 1/20 0.48
POLB P06746 2/20 0.46
PIK3CD O00329 3/20 0.44
MAPT P10636 2/20 0.44
NPC1 O15118 1/20 0.43
PDE7A Q13946 2/20 0.43
HTT P42858 2/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4234298 0.92 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL4233567 0.87 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL27789328 0.87 ALDH1A1 (0.57) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL4232766 0.85 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL1703381 0.84 ALDH1A1 (0.60) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL4229400 0.80 POLB (0.51) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL4234481 0.79 PDE10A (0.45) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL4961253 0.78 PDE4A (0.56) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL4229663 0.77 USP2 (0.53) ALDH1A1SMN1; SMN2MEN1KMT2AGAA
SCHEMBL4238926 0.77 PDE4B (0.42) ALDH1A1SMN1; SMN2RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097422-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS Eli Lilly & Co. (US) 2009-09-09 EP disclosed
WO-2008064018-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS ELI LILLY & CO. (US) 2008-05-29 WO disclosed